XML 42 R20.htm IDEA: XBRL DOCUMENT
v2.4.0.6

Note 13 - Business Segment Reporting | 12 Months Ended
--- | ---
May 27, 2012
Segment Reporting Disclosure [Text Block] | 13. Business Segment Reporting The Company manages its business operations through four strategic business units. Based upon the information reported to the chief operating decision maker, who is the Chief Executive Officer, the Company has the following reportable segments: the Food Products Technology segment, the Food Export segment, the Hyaluronan-based Biomaterials segment and the Technology Licensing segment. The Food Products Technology segment markets and packs specialty packaged whole and fresh-cut vegetables that incorporate the BreatheWay specialty packaging for the retail grocery, club store and food services industry. In addition, the Food Products Technology segment sells BreatheWay packaging to partners for non-vegetable products. The Food Export segment consists of revenues generated from the purchase and sale of primarily whole commodity fruit and vegetable products to Asia and domestically. The HA-based Biomaterials segment sells products utilizing hyaluronan, a naturally occurring polysaccharide that is widely distributed in the extracellular matrix of connective tissues in both animals and humans for medical use primarily in the Ophthalmic, Orthopedic and Veterinary markets. The Technology Licensing segment licenses Landec’s patented Intellicoat seed coatings to the farming industry and licenses the Company’s Intelimer polymers for personal care products and other industrial products. Corporate includes corporate general and administrative expenses, non Food Products Technology and non HA-based Biomaterials interest income and Company-wide income tax expenses. All of the assets of the Company are located within the United States of America. The Company’s international sales were as follows (in millions):
|  | May 27, 2012 |  |  | May 29, 2011 |  |  | May 30, 2010 |
Taiwan |  | $ | 22.7 |  |  | $ | 21.3 |  |  | $ | 20.3 |
Indonesia |  | $ | 23.0 |  |  | $ | 20.2 |  |  | $ | 13.7 |
Canada |  | $ | 20.8 |  |  | $ | 18.4 |  |  | $ | 15.5 |
Belgium |  | $ | 15.6 |  |  | $ | 16.7 |  |  | $ | 0.3 |
Japan |  | $ | 11.1 |  |  | $ | 8.4 |  |  | $ | 8.8 |
All Other Countries |  | $ | 21.3 |  |  | $ | 18.8 |  |  | $ | 10.0 |
Operations by segment consisted of the following (in thousands):
Fiscal Year Ended May 27, 2012 |  | Food Products Technology |  |  | Food Export |  |  | Hyaluronan-based Biomaterials |  |  | Technology Licensing |  |  | Corporate |  |  | TOTAL |
Net sales |  | $ | 207,582 |  |  | $ | 71,485 |  |  | $ | 34,283 |  |  | $ | 4,202 |  |  | $ | — |  |  | $ | 317,552 |
International sales |  | $ | 20,528 |  |  | $ | 71,054 |  |  | $ | 22,904 |  |  | $ | — |  |  | $ | — |  |  | $ | 114,486 |
Gross profit |  | $ | 25,237 |  |  | $ | 4,900 |  |  | $ | 17,994 |  |  | $ | 4,007 |  |  | $ | — |  |  | $ | 52,138 |
Net income (loss) |  | $ | 17,527 |  |  | $ | 2,269 |  |  | $ | 7,672 |  |  | $ | (269 | ) |  | $ | (14,503 | ) |  | $ | 12,696 |
Identifiable assets |  | $ | 169,541 |  |  | $ | 18,425 |  |  | $ | 81,927 |  |  | $ | 7,713 |  |  | $ | 86 |  |  | $ | 277,692 |
Depreciation and amortization |  | $ | 3,191 |  |  | $ | 7 |  |  | $ | 2,242 |  |  | $ | 181 |  |  | $ | — |  |  | $ | 5,621 |
Capital expenditures |  | $ | 2,498 |  |  | $ | — |  |  | $ | 2,798 |  |  | $ | 75 |  |  | $ | — |  |  | $ | 5,371 |
Dividend income |  | $ | 1,125 |  |  | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | 1,125 |
Interest income |  | $ | 30 |  |  | $ | — |  |  | $ | 129 |  |  | $ | — |  |  | $ | 21 |  |  | $ | 180 |
Interest expense |  | $ | 178 |  |  | $ | — |  |  | $ | 751 |  |  | $ | — |  |  | $ | — |  |  | $ | 929 |
Income tax expense |  | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | 7,185 |  |  | $ | 7,185 |
Fiscal Year Ended May 29, 2011 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Net sales |  | $ | 175,664 |  |  | $ | 61,663 |  |  | $ | 32,505 |  |  | $ | 6,897 |  |  | $ | — |  |  | $ | 276,729 |
International sales |  | $ | 18,580 |  |  | $ | 61,214 |  |  | $ | 24,024 |  |  | $ | — |  |  | $ | — |  |  | $ | 103,818 |
Gross profit |  | $ | 18,888 |  |  | $ | 3,901 |  |  | $ | 17,231 |  |  | $ | 6,675 |  |  | $ | — |  |  | $ | 46,695 |
Net income (loss) |  | $ | 8,200 |  |  | $ | 1,617 |  |  | $ | 7,278 |  |  | $ | (2,504 | ) |  | $ | (10,671 | ) |  | $ | 3,920 |
Identifiable assets |  | $ | 88,241 |  |  | $ | 16,320 |  |  | $ | 83,954 |  |  | $ | 7,527 |  |  | $ | 10,270 |  |  | $ | 206,312 |
Depreciation and amortization |  | $ | 3,174 |  |  | $ | 8 |  |  | $ | 1,972 |  |  | $ | 159 |  |  | $ | — |  |  | $ | 5,313 |
Capital expenditures |  | $ | 3,620 |  |  | $ | — |  |  | $ | 2,817 |  |  | $ | 247 |  |  | $ | — |  |  | $ | 6,684 |
Dividend income |  | $ | 328 |  |  | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | 328 |
Interest income |  | $ | 129 |  |  | $ | — |  |  | $ | 164 |  |  | $ | — |  |  | $ | 137 |  |  | $ | 430 |
Interest expense |  | $ | 2 |  |  | $ | — |  |  | $ | 818 |  |  | $ | — |  |  | $ | — |  |  | $ | 820 |
Income tax expense |  | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | 4,181 |  |  | $ | 4,181 |
Impairment charges |  | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | 4,780 |  |  | $ | — |  |  | $ | 4,780 |
Fiscal Year Ended May 30, 2010 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Net sales |  | $ | 175,046 |  |  | $ | 54,926 |  |  | $ | 1,457 |  |  | $ | 6,795 |  |  | $ | — |  |  | $ | 238,224 |
International sales |  | $ | 15,714 |  |  | $ | 52,319 |  |  | $ | 603 |  |  | $ | — |  |  | $ | — |  |  | $ | 68,636 |
Gross profit |  | $ | 22,514 |  |  | $ | 3,906 |  |  | $ | 815 |  |  | $ | 6,531 |  |  | $ | — |  |  | $ | 33,766 |
Net income (loss) |  | $ | 11,051 |  |  | $ | 1,789 |  |  | $ | 13 |  |  | $ | 2,647 |  |  | $ | (11,516 | ) |  | $ | 3,984 |
Identifiable assets |  | $ | 75,280 |  |  | $ | 13,979 |  |  | $ | 79,604 |  |  | $ | 11,848 |  |  | $ | 19,486 |  |  | $ | 200,197 |
Depreciation and amortization |  | $ | 3,055 |  |  | $ | 8 |  |  | $ | 141 |  |  | $ | 160 |  |  | $ | — |  |  | $ | 3,364 |
Capital expenditures |  | $ | 4,212 |  |  | $ | — |  |  | $ | 739 |  |  | $ | 241 |  |  | $ | — |  |  | $ | 5,192 |
Interest income |  | $ | 223 |  |  | $ | — |  |  | $ | 8 |  |  | $ | — |  |  | $ | 603 |  |  | $ | 834 |
Interest expense |  | $ | 12 |  |  | $ | — |  |  | $ | 76 |  |  | $ | — |  |  | $ | — |  |  | $ | 88 |
Income tax expense |  | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | 4,262 |  |  | $ | 4,262 |
Impairment charges |  | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | 1,000 |  |  | $ | — |  |  | $ | 1,000 |

X
- Definition The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 29 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8864-108599 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 30 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8906-108599 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 32 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8933-108599 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 35 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8984-108599 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8380-108599 Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 10 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8538-108599 Reference 7: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 42 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e9054-108599 Reference 8: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 12 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8595-108599 Reference 9: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 131 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 10: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 34 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8981-108599 Reference 11: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 33 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8971-108599 Reference 12: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 26 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8844-108599 Reference 13: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 31 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8924-108599 Reference 14: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 40 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e9031-108599 Reference 15: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 41 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e9038-108599 + Details
Name: | us-gaap_SegmentReportingDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration